Club drugs:: old medicines as new party drugs

被引:16
作者
Abanades, S
Peiró, AM
Farré, M
机构
[1] Hosp Mar, Unidad Farmacol, IMIM, Barcelona 08003, Spain
[2] Univ Autonoma Barcelona, Dept Farmacol Terapeut & Toxicol, E-08193 Barcelona, Spain
来源
MEDICINA CLINICA | 2004年 / 123卷 / 08期
关键词
club drugs; ketamine; dextromethorphan; nitrous oxide; gamma-hydroxybutyric acid; GHB; rave;
D O I
10.1016/S0025-7753(04)74499-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During the last few years the term club drugs has been used for defining an heterogeneous group of chemical substances in permanent evolution, that are consumed for recreational purposes. These substances have been extensively used, firstly by the Rave culture and later by the so called Club culture. These movements are characterized by the search of amplified sensations, by means of the combination of electronic music, marathon dancing and substance abuse. After years with a predominating consumption of designer amphetamines in these groups, it seems that the use of another type of substances is increasing, fundamentally drugs with hallucinogenic effects. This review focus in four of these substances; ketamine, dextromethorphan, nitrous oxide and gamma-hydroxybutyric acid (GHB, liquid ecstasy), and includes a discussion of their pharmacology, recreational use, adverse effects and patient management. These drugs are, at he same time, drugs of abuse and medicines with concrete indications in therapeutics, with an important increase of their consumption in the last few years. The Rave and Club cultures are also described.
引用
收藏
页码:305 / 311
页数:7
相关论文
共 80 条
[41]  
Jansen KLR., 2003, ADICCIONES KETAMINA, V15, P135
[42]   Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin [J].
Jevtovic-Todorovic, V ;
Todorovic, SM ;
Mennerick, S ;
Powell, S ;
Dikranian, K ;
Benshoff, N ;
Zorumski, CF ;
Olney, JW .
NATURE MEDICINE, 1998, 4 (04) :460-463
[43]   Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia [J].
Kegeles, LS ;
Abi-Dargham, A ;
Zea-Ponce, Y ;
Rodenhiser-Hill, J ;
Mann, JJ ;
Van Heertum, RL ;
Cooper, TB ;
Carlsson, A ;
Laruelle, M .
BIOLOGICAL PSYCHIATRY, 2000, 48 (07) :627-640
[44]   Ketamine: Teaching an old drug new tricks [J].
Kohrs, R ;
Durieux, ME .
ANESTHESIA AND ANALGESIA, 1998, 87 (05) :1186-1193
[45]  
KRONBACH T, 1991, METHOD ENZYMOL, V206, P509
[46]   Effects of ketamine in normal and schizophrenic volunteers [J].
Lahti, AC ;
Weiler, MA ;
Michaelidis, T ;
Parwani, A ;
Tamminga, CA .
NEUROPSYCHOPHARMACOLOGY, 2001, 25 (04) :455-467
[47]  
Laita AD, 1998, MED CLIN-BARCELONA, V111, P458
[48]   Raves, drugs and experience: drug use by a sample of people who attend raves in Western Australia [J].
Lenton, S ;
Boys, A ;
Norcross, K .
ADDICTION, 1997, 92 (10) :1327-1337
[49]   A tale of novel intoxication:: A review of the effects of γ-hydroxybutyric acid with recommendations for management [J].
Li, J ;
Stokes, SA ;
Woeckener, A .
ANNALS OF EMERGENCY MEDICINE, 1998, 31 (06) :729-736
[50]   The gamma-hydroxybutyrate signalling system in brain: Organization and functional implications [J].
Maitre, M .
PROGRESS IN NEUROBIOLOGY, 1997, 51 (03) :337-361